Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herb/Drug Interaction Research Could Include Clinical, Behavioral Studies

This article was originally published in The Tan Sheet

Executive Summary

Future research on herb/drug interactions could range from clinical trials of botanicals to behavioral studies of consumer use patterns, according to speakers at an American Society of Clinical Pharmacology & Therapeutics workshop in Bethesda, Md. July 22-23

You may also be interested in...



Isoflavone Supplement Hot Flash Reduction Similar To Placebo – JAMA Study

Overweight women who took Novogen's isoflavone-containing Promensil or Rimostil supplements experienced a greater reduction in hot flashes than women taking placebo, according to a study published in the July 9 Journal of the American Medical Association

Isoflavone Supplement Hot Flash Reduction Similar To Placebo – JAMA Study

Overweight women who took Novogen's isoflavone-containing Promensil or Rimostil supplements experienced a greater reduction in hot flashes than women taking placebo, according to a study published in the July 9 Journal of the American Medical Association

Isoflavone Supplement Hot Flash Reduction Similar To Placebo – JAMA Study

Overweight women who took Novogen's isoflavone-containing Promensil or Rimostil supplements experienced a greater reduction in hot flashes than women taking placebo, according to a study published in the July 9 Journal of the American Medical Association

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094328

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel